Press Coverage

Mauna Kea Technologies Partners with Metrodora to Create First U.S. Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults

6 June 2024

Mauna Kea Technologies and Metrodora Institute, a leading multispecialty healthcare institute, announced the formation of a new partnership.

This collaboration aims to establish Metrodora Institute as the first U.S. Center of Excellence that will serve as the model of patient care and physician training on the use of Cellvizio for identifying and treating food intolerances in patients suffering from Irritable Bowel Syndrome (IBS).

Read the complete article

Latest News

Mauna Kea Technologies Announces 2025 Half-Year Results 

Mauna Kea Technologies Announces 2025 Half-Year Results 

Mauna Kea Technologies Presents the Final Terms of its Safeguard Plan

Mauna Kea Technologies Presents the Final Terms of its Safeguard Plan

Mauna Kea Technologies and Endotherapeutics Announce Cellvizio® First Australian Orders, Advancing CellTolerance® Commercial Expansion 

Mauna Kea Technologies and Endotherapeutics Announce Cellvizio® First Australian Orders, Advancing CellTolerance® Commercial Expansion 

No results found.